Cite
CAGE‐B and SAGE‐B models better predict the hepatitis B virus‐related hepatocellular carcinoma after 5‐year entecavir treatment than PAGE‐B.
MLA
Chon, Hye Yeon, et al. “CAGE‐B and SAGE‐B Models Better Predict the Hepatitis B Virus‐related Hepatocellular Carcinoma after 5‐year Entecavir Treatment than PAGE‐B.” Journal of Digestive Diseases, vol. 24, no. 2, Feb. 2023, pp. 113–21. EBSCOhost, https://doi.org/10.1111/1751-2980.13172.
APA
Chon, H. Y., Lee, H. A., Park, S. Y., Seo, Y. S., Kim, S. G., Lee, C. H., Lee, T. H., Ahn, S. H., Wong, V. W., Yip, T. C., Liang, L. Y., Kim, I. H., Wong, G. L., & Kim, S. U. (2023). CAGE‐B and SAGE‐B models better predict the hepatitis B virus‐related hepatocellular carcinoma after 5‐year entecavir treatment than PAGE‐B. Journal of Digestive Diseases, 24(2), 113–121. https://doi.org/10.1111/1751-2980.13172
Chicago
Chon, Hye Yeon, Han Ah Lee, Soo Young Park, Yeon Seok Seo, Sang Gyune Kim, Chang Hun Lee, Tae Hee Lee, et al. 2023. “CAGE‐B and SAGE‐B Models Better Predict the Hepatitis B Virus‐related Hepatocellular Carcinoma after 5‐year Entecavir Treatment than PAGE‐B.” Journal of Digestive Diseases 24 (2): 113–21. doi:10.1111/1751-2980.13172.